Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.
about
Dispersing biofilms with engineered enzymatic bacteriophageInsights into Bacteriophage Application in Controlling Vibrio SpeciesGenetically Engineered Phages: a Review of Advances over the Last DecadeEcology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm BacteriaPhage therapy against Enterococcus faecalis in dental root canalsBacteriophages with the ability to degrade uropathogenic Escherichia coli biofilmsAryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.First complete genome sequence of two Staphylococcus epidermidis bacteriophages.Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.Effective removal of staphylococcal biofilms by the endolysin LysH5.In vivo fluorescence imaging of biomaterial-associated inflammation and infection in a minimally invasive manner.Genomic characterization of two Staphylococcus epidermidis bacteriophages with anti-biofilm potentialHolins in bacteria, eukaryotes, and archaea: multifunctional xenologues with potential biotechnological and biomedical applications.Green biocides, a promising technology: current and future applications to industry and industrial processes.An Enterotoxin-Bearing Pathogenicity Island in Staphylococcus epidermidis.Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter modelStaphylococcus epidermidis bacteriophages from the anterior nares of humansApplication of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis.Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infectionsBiofilm models of polymicrobial infection.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities.Detection of Staphylococcus epidermidis by a Quartz Crystal Microbalance Nucleic Acid Biosensor Array Using Au Nanoparticle Signal Amplification.Staphylococcus epidermidis device-related infections: pathogenesis and clinical management.Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective.Evaluation of a 2-aminoimidazole variant as adjuvant treatment for dermal bacterial infections.Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision MedicineBiofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.Mini-review: Antimicrobial central venous catheters--recent advances and strategies.Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.New approaches for treating staphylococcal biofilm infections.Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies.Development of broad-spectrum antibiofilm drugs: strategies and challenges.Bacteriophage Can Prevent Encrustation and Blockage of Urinary Catheters by Proteus mirabilis.Biofilm control with natural and genetically-modified phages.A review of the recent advances in antimicrobial coatings for urinary catheters.Phage Therapy in the Era of Synthetic Biology.Bacteriophages infecting Propionibacterium acnes.
P2860
Q24684087-01BF1959-F506-430A-AFA8-B070BCA40BEEQ26739744-AFD34814-BFE4-4465-871A-EE394766A045Q26744156-DC0D77CE-6230-40C0-B7FB-06AF15DD080BQ26786947-0904A20A-21BB-4D64-87D2-719A3460F5DCQ28071930-18B76306-2A89-48D7-B49D-3783A6567DE7Q28384149-803B3D63-D5B8-402A-B6CC-FFA29595D67FQ30482245-36736B9F-5E37-4100-8C01-BB2B7DA8999BQ33266723-8D1DFE42-33C9-4F00-808F-C5E454F6F6A8Q33417531-7D9E7197-5DC2-4B13-9896-C1F54D3BEBE2Q33509952-C1A636B5-B645-4F5A-A78C-11671D70DEF0Q34156197-1C4D655F-E251-4EE9-82DE-75E0BB8C44DFQ34161108-B27EA8B1-FB4B-44AD-BE24-0BE4AC27559AQ34297779-E0213CCE-6CD7-452C-A091-ACA39677FAA4Q34435161-F81198BF-3CA0-4CDE-B812-C525F3156AA4Q34975378-B12FD8A6-CD7D-4BD0-8973-E423E5602161Q35095764-ED847764-74FE-4001-9648-C51ED0CE2739Q35105990-4BA1751A-38F0-4B68-A19C-771E12E8EC53Q35530799-A44A8EBB-FF34-42F0-897A-46F61BF1461BQ35599168-4DF569CC-CD02-4ACA-AAD0-BCCB831F84F0Q35714452-B37FAD85-4B79-40A4-B82F-069950F37F29Q35848074-9E90E99E-39C2-4C0D-87CF-89B616ED0333Q35853204-EA698EA1-1A75-421A-AF97-79198165A08CQ36364160-DACFE337-A33C-46B3-92C5-21F28FBF3682Q37000116-F779A49F-6A23-48BE-A123-B3EE1891C89CQ37322685-904741D7-4565-421A-8AC7-3FBE084B7527Q37341004-D66B8EAA-62E3-41BE-A7FC-136ABD974F91Q37590383-934D4A54-93AB-43B5-8C50-DDD617F99570Q37644025-DABBF492-9E81-48F1-9C20-093E9A123A72Q37860818-D7994FE2-2C71-4F4F-B3A5-C46B2CD45D0DQ37896090-EB029A13-7086-419B-8245-B964CDF0F589Q37928694-CB10D898-25D2-469A-B097-58B2BA39C48DQ37929756-E7D754AD-23A3-428D-9A8F-C62BEB8E4D71Q37970722-EFCAA87E-1FD9-48C2-958D-647B76D340F8Q38166786-DBB6E025-99B9-44B8-B933-4CBF525E3896Q38522806-8875F14A-7A13-4A2E-AB05-546ABC023339Q38741221-6AAEC807-A3F5-4797-860C-90D6589DCA39Q38756810-40100CF9-C967-4D07-A63D-C2049220AFDDQ38787366-F41DBBA6-E8DE-4477-BCA4-29EC1994D8FAQ38915649-821CA579-7C4C-4E3C-8E29-1DCDC211A22EQ40640644-932984B5-3D18-4B25-BEF8-2D612CC3B13A
P2860
Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@ast
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@en
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@nl
type
label
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@ast
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@en
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@nl
prefLabel
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@ast
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@en
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@nl
P2860
P921
P1476
Using bacteriophages to reduce ...... by Staphylococcus epidermidis.
@en
P2093
John J Curtin
Rodney M Donlan
P2860
P304
P356
10.1128/AAC.50.4.1268-1275.2006
P407
P577
2006-04-01T00:00:00Z